Mission
To develop and provide diagnosis products and metabolomic services aiming to contribute to the progression of knowledge, prevention, diagnosis and treatment of complex diseases submitted to research on the company.
Vision
To be the best-in class performer in metabolomics and its application in the development of diagnostic systems for highly prevalent complex diseases in Europe and worldwide.
Strategy
The activity of the company is centered in the area of human health and its objective is to identify, validate, patent and commercialize early diagnostic and/or prognostic systems, as well as therapeutic targets implied in the development of hepatic diseases and other great prevalence complex pathologies. To accomplish this we use innovative technology in genomics, proteomics, metabolomics and bioinformatics and have established a complete and highly productive platform which supports the advance of our developments.
With this web OWL Genomics intends to provide users with information to better understand their health and their diagnosed illnesses. You should consult with a qualified
physician for diagnosis and for answers to your personal questions/circunstances.
Last update: 09/06/2010
This site complies with the HONcode standard for trustworthy health information:
verify here.